ArticleFrontiers in surgery2025
Single center clinical analysis of prognostic factors affecting invasive fungal rhinosinusitis.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the factors affecting the prognosis of invasive fungal rhinosinusitis (IFRS) by statistically analyzing clinical data collected from a single-center cohort of patients. Methods: A retrospective analysis was conducted on 43 hospitalized patients with histopathologically confirmed IFRS at Shandong Provincial Hospital between January 2019 and March 2024. Epidemiological data, clinical symptoms and signs, laboratory findings, imaging results, and treatment interventions were extracted from medical records. Clinical outcomes were followed up for over six months. Retrospective analyses were performed to identify factors influencing IFRS prognosis. Results: A total of 43 patients were included, comprising 20 cases of acute IFRS and 23 cases of chronic IFRS. Among them, 15 patients achieved full recovery, 19 experienced sequelae, and 9 died. There were 25 males and 18 females, with a median age of 65 years (range, 24-86). Thirty-two patients (74.4%) had diabetes, and 8 patients (18.6%) had conditions associated with immunosuppression, including malignancies, autoimmune diseases. Patients with acute IFRS exhibited significantly higher C-reactive protein levels ( Conclusion: Univariate analysis indicated that acute onset, immunosuppression, elevated D-dimer, lymphocyte, and blood glucose levels, as well as orbital and intracranial fungal invasion, were negative prognostic factors. Immunosuppression-including advanced age, diabetes, and hematological malignancies-was a major underlying cause of IFRS. Intracranial infection had a significant impact on mortality. Positive prognostic factors included timely and standardized systemic antifungal therapy, intrathecal antifungal administration in cases of intracranial involvement, anticoagulant treatment, prompt surgical debridement, and, when necessary, repeated surgical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.